ColoSTAT® is indicated to screen adults, aged 40 to 85, at average risk for developing CRC. The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumours are present. Generated data, along with the individual's age and sex, are entered into the ColoSTAT® proprietary algorithm software to produce a CRC ‘likelihood score’.